Equity in STI Testing Act

The Equity in STI Testing Act requires Medicare Advantage, Medicaid, CHIP, TRICARE, and the Department of Veterans Affairs to cover screening tests for HIV, gonorrhea, syphilis, trichomoniasis, and chlamydia without charging beneficiaries any out-of-pocket costs. The bill directly affects patients enrolled in these federal health programs by eliminating copayments and deductibles specifically for these preventive screenings. It also mandates that the Indian Health Service provide these tests to eligible Native Americans at no cost, regardless of whether the services are typically authorized under their purchased or referred care systems. These changes take effect on different timelines depending on the specific program, with some provisions applying immediately upon enactment and others starting in the following calendar year.